AstraZeneca Pharma India has granted certain authority (through a Delegation of Authority (DOA)) to Pfizer, which shall include, authority to carry out the activities of pricing and reimbursement negotiations, promotional, marketing, tendering, bidding, and distribution in relation to the identified injectable antibiotic products. Pursuant to this, Meronem IV injection which is currently marketed in India by AstraZeneca Pharma India is expected to be transitioned to Pfizer.
AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The company operates through two segments Healthcare and Clinical Trial.
